多维策略评价射干与鸢尾的化学与生物活性差异
研究采用植物代谢组学、数字参考标准分析器和生物活性测定,比较射干(BC)与鸢尾(ITM)的化学成分、质量与活性差异。PCA和OPLS-DA显示两者化学轮廓明显不同,鉴定出6个差异化合物;BC抗癌效果较好,ITM保肝活性较强,结论为两者不可混用。
要点
- 射干与鸢尾化学轮廓显著不同,鉴定出6个差异化合物。
- 射干抗癌效果优于鸢尾,与鸢尾苷元高丰度相关。
- 鸢尾保肝活性强于射干,与鸢尾苷高丰度相关。
核心结论
- 射干与鸢尾在化学成分和生物活性上存在显著差异,不能混合用于工业生产和临床用药。
研究设计与样本
- 研究采用植物代谢组学、数字参考标准分析器和生物活性测定多种技术比较射干与鸢尾。
主要发现
- PCA和OPLS-DA得分图显示射干与鸢尾化学轮廓明显不同,并鉴定出6个差异化合物。
- 数字参考标准分析器分别建立射干10个和鸢尾8个化合物的指纹图谱,仅用两个对照品即准确鉴定。
- 生物活性测定中,射干因鸢尾苷元高丰度而抗癌效果优于鸢尾,鸢尾因鸢尾苷高丰度而保肝活性强于射干。
临床怎么用
- 临床与工业生产中应区分射干与鸢尾,避免混用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Belamcanda chinensis (L.) DC. (BC) belongs to the family of Iridaceae and is widely cultivated and used in many Chinese patent medicine and Chinese medicinal formulae. However, due to the high similarities in appearance such as color and shape to Iris tectorum Maxim (ITM), another plant from the same family, BC is often confused or even misused with ITM. METHODS: Therefore, in order to distinguish the chemical constituents, qualities and biological activities of BC and ITM, multiple technologies including plant metabolomics, digital reference standard (DRS) analyzer and biological activities assay were employed to provide a sufficient basis for their practical applications. RESULTS: In plant metabolomics, the PCA and OPLS-DA score plot indicated the obvious differences in chemical profiling between BC and ITM and 6 compounds were successfully identified to contribute to the differences. In DRS study, the fingerprints of 10 and 8 compounds in BC and ITM were developed based on DRS analyzer, respectively, involving relative retention time (RRT) method and linear calibration using two reference substances (LCTRS) technique. The DRS analyzer also accurately identified 10 and 8 compounds from BC and ITM, respectively, by using only two reference standards. In biological activities assay, BC had a better anticancer effect than ITM due to the high abundance of irigenin, while ITM showed stronger hepatoprotective activity than BC because of the high abundance of tectoridin. CONCLUSIONS: Therefore, due to the significant differences of B. chinensis and I. dichotoma in chemical composition and biological activities, the current studies strongly proved that these two medicinal plants could not be mixed in industrial production and clinical medication.
引用
- Zhou H, Zhang Y, Liang H, et al. A novel multidimensional strategy to evaluate Belamcanda chinensis (L) DC and Iris tectorum Maxim based on plant metabolomics, digital reference standard analyzer and biological activities evaluation. Chin Med. 2021. PMID: 34446058. doi:10.1186/s13020-021-00494-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。